Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (121-130 of 301) with videos related to

Pageof 31
Sort By:
British Journal of Cancer|July 1, 1986
Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumventionR Supino, E Prosperi, F Formelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1997
TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patientsC Maccalli, C Farina, M Sensi, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Adoptive immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic adenocarcinoma modelM Rodolfo, C Salvi, C Bassi, et al.
Experimental and Clinical Immunogenetics|January 1, 1990
H-2 class I gene analysis in 3-methylcholanthrene-induced murine fibrosarcomasC Castelli, F Mazzucchelli, M Sensi, et al.
International Journal of Cancer|April 1, 1993
T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysisA Anichini, R Mortarini, S Alberti, et al.
Bulletin Du Cancer|January 1, 1982
Abnormal expression of histocompatibility antigens on cancer cellsG Parmiani, M A Pierotti, M P Colombo, et al.
Cancer Research|August 15, 1992
Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectinR Mortarini, A Gismondi, A Santoni, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosourea on spontaneous metastases of a non-immunogenic murine tumourG Acerbis, L Cleris, M Rodolfo, et al.
Transplantation Proceedings|March 1, 1980
Alien H-2 antigens (H-2k) appearing on a methylcholanthrene-induced tumor (H-2d): biochemical characterizationM J Rogers, M A Pierotti, G Parmiani, et al.
The International Journal of Biological Markers|July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytesL Rivoltini, G Cattoretti, F Arienti, et al.
Pageof 31

Showing results (121-130 of 301) with videos related to

Sort By:
Pageof 31
British Journal of Cancer|July 1, 1986
Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumventionR Supino, E Prosperi, F Formelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1997
TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patientsC Maccalli, C Farina, M Sensi, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Adoptive immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic adenocarcinoma modelM Rodolfo, C Salvi, C Bassi, et al.
Experimental and Clinical Immunogenetics|January 1, 1990
H-2 class I gene analysis in 3-methylcholanthrene-induced murine fibrosarcomasC Castelli, F Mazzucchelli, M Sensi, et al.
International Journal of Cancer|April 1, 1993
T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysisA Anichini, R Mortarini, S Alberti, et al.
Bulletin Du Cancer|January 1, 1982
Abnormal expression of histocompatibility antigens on cancer cellsG Parmiani, M A Pierotti, M P Colombo, et al.
Cancer Research|August 15, 1992
Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectinR Mortarini, A Gismondi, A Santoni, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosourea on spontaneous metastases of a non-immunogenic murine tumourG Acerbis, L Cleris, M Rodolfo, et al.
Transplantation Proceedings|March 1, 1980
Alien H-2 antigens (H-2k) appearing on a methylcholanthrene-induced tumor (H-2d): biochemical characterizationM J Rogers, M A Pierotti, G Parmiani, et al.
The International Journal of Biological Markers|July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytesL Rivoltini, G Cattoretti, F Arienti, et al.
Pageof 31